Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02259621 |
|---|---|
| Brief Title: | Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC (NA_00092076) |
| First Submitted : | September 18, 2014 |
| First Submitted that Met QC Criteria : | October 3, 2014 |
| First Posted : | October 8, 2014 (Estimate) |
| Results First Submitted : | November 17, 2023 |
| Results First Submitted that Met QC Criteria : | February 22, 2024 |
| Results First Posted : | March 20, 2024 |
| Certification/Extension First Submitted : | October 3, 2023 |
| Certification/Extension First Posted : | November 3, 2023 |
| Last Update Submitted that Met QC Criteria : | February 22, 2024 |
| Last Update Posted : | March 20, 2024 |